rdf-syntax-grammar
mods:
  schema location: http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd
  title info:
    title: Prostate Cancer Screening
  name:
    name part: Ankerst, Donna P.
    role:
      role term: editor.
  name:
    name part: Tangen, Catherine M.
    role:
      role term: editor.
  name:
    name part: Thompson, Ian M.
    role:
      role term: editor.
  name:
    name part: SpringerLink (Online service)
  type of resource: text
  origin info:
    place:
      place term: xxu
    date issued: 2009
    edition: Second Edition.
    issuance: monographic
  language:
    language term: eng
  physical description:
    form: electronic
    form: electronic resource
    reformatting quality: access
    form: remote
    extent: XVI, 397 p. online resource.
  abstract: More than one in six men will develop prostate cancer in their lifetime. In recent years there has been an explosion of information regarding PSA screening and biomarkers for the disease. In Prostate Cancer Screening, Second Edition, the world’s leading experts on prostate cancer detection update the first edition with the latest findings. The book incorporates a series of thoughtful and cutting-edge works from the world’s experts in prostate cancer screening, ranging from the current status quo of prostate cancer screening across the globe to consensus on optimal utilization of the traditional PSA and DRE tests, to cutting-edge research in new biomarkers, biomeasures, and extended risk algorithms for prostate cancer. An additional chapter covers family-based linkage analysis as well as possible pitfalls in prostate cancer biomarker evaluation studies. Timely and authoritative, Prostate Cancer Screening, Second Edition, is an essential text for urologists, oncologists and family physicians, as well as researchers in the biomarker industry who seek methods to better develop and support markers and measures of prostate cancer.
  table of contents: Trends in Prostate Cancer Screening -- Overview of US Prostate Cancer Trends in the Era of PSA Screening -- Trends in Prostate Cancer Screening: Overview of the UK -- Trends in Prostate Cancer Screening: Canada -- Trends in Prostate Cancer Screening – Overview of Europe -- Prostate-Specific Antigen -- Evolution of Prostate-Specific Antigen for Screening -- The Performance Characteristics of Prostate-Specific Antigen for Prostate Cancer Screening -- The Performance of PSA for Predicting Prostate Cancer After a Prior Negative Prostate Biopsy -- Subfractions and Derivatives of Total Prostate-Specific Antigen in the Early Detection of Prostate Cancer -- PSA Velocity at Presentation as a Predictor of Prostate Cancer Aggressiveness -- Risk Assessment for Prostate Cancer -- Nomograms for Prostate Cancer -- Decision Aid Criteria and Artificial Neural Networks for Optimizing Prostate Cancer Risk Prediction -- Development of the Prostate Cancer Prevention Trial Prostate Cancer Risk Calculator -- Integration of Risk Assessment in Prostate Cancer Screening -- Family History of Prostate Cancer During Rapidly Increasing Incidence -- Recent Biomarkers for Prostate Cancer -- PSA Isoforms: [?2]proPSA Significant Adjunct to Free PSA -- PCA3 -- Transcriptional Profiling of Prostate Cancer: Biomarker Identification and Clinical Applications -- Biomarkers for Prostate Cancer Detection: Family-Based Linkage Analysis and Case–Control Association Studies -- GSTP1 Hypermethylation for Prostate Cancer Detection -- EPCA and EPCA-2 as Potential Biomarkers for Prostate Cancer Detection -- Design and Methodologic Considerations in Biomarker Studies -- Toward a Robust System for Biomarker Triage and Validation – EDRN Experience -- Statistical Evaluation of Markers and Risk Tools for Prostate Cancer Classification and Prediction -- Pitfalls in Prostate Cancer Biomarker Evaluation Studies -- Building upon Recently Completed and Ongoing Prospective Trials -- Prostate-Specific Antigen and Its Role on…
  note: edited by Donna P. Ankerst, Catherine M. Tangen, Ian M. Thompson.
  subject:
    topic: Medicine
  subject:
    topic: Health informatics
  subject:
    topic: Oncology
  subject:
    topic: Urology
  subject:
    topic: Epidemiology
  subject:
    topic: Medicine & Public Health
  subject:
    topic: Oncology
  subject:
    topic: Urology
  subject:
    topic: Epidemiology
  subject:
    topic: Medicine/Public Health, general
  subject:
    topic: Health Informatics
  classification: RC254-282
  classification: 616.994
  related item:
    title info:
      title: Springer eBooks
  related item:
    title info:
      title: Current Clinical Urology
  identifier: 9781603272810
  identifier: http://dx.doi.org/10.1007/978-1-60327-281-0
  record info:
    record creation date: 100301
    record change date: 20151204163304.0
    record identifier: 978-1-60327-281-0